Skip to content

Protective Effect of Intraoperative Parathyroid Gland Auxiliary Recognition System in Thyroid Malignant Tumor Operation

Protective Effect of Intraoperative Parathyroid Gland Auxiliary Recognition System in Thyroid Malignant Tumor Operation

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04560426
Enrollment
200
Registered
2020-09-23
Start date
2020-10-31
Completion date
2022-10-31
Last updated
2020-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intraoperative Monitoring, Parathyroid, Thyroid Cancer

Brief summary

This intraoperative parathyroid gland auxiliary recognition system uses the principle of parathyroid gland autofluorescence to assist surgeons in accurately identifying and protecting parathyroid glands during surgery, reducing the possibility of postoperative hypoparathyroidism. This study will explore the protective effect of the parathyroid gland auxiliary recognition instrument on parathyroid function during thyroid malignant tumor surgery through reasonable grouping.

Interventions

DEVICEIntraoperative parathyroid gland auxiliary recognition system

The enrolled patients are grouped according to whether or not to use the intraoperative parathyroid auxiliary recognition system.

Sponsors

Fudan University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

1. Patients with unilateral thyroid malignancies who require surgical treatment between the ages of 20-50. 2. No history of neck surgery and radiotherapy. 3. There is no evidence of parathyroid tumor invasion in preoperative imaging assessment. 4. No abnormal calcium metabolism disease. 5. No abnormalities in blood calcium and blood PTH before operation. 6. No allergy to contrast agents. 7. The patient or his agent signs an informed consent statement.

Exclusion criteria

1. Does not meet the entry criteria; 2. Parathyroid glands were found to be invaded by tumor during operation and the parathyroid glands could not be preserved.

Design outcomes

Primary

MeasureTime frameDescription
Serum Calcium level24 hours after surgeryPatients' serum Calcium level at 24 hours after surgery.
PTH24 hours after surgeryPatients' serum PTH level at 24 hours after surgery.

Countries

China

Contacts

Primary ContactYu Wang, Doctor
neck130@sina.com+86 13817311886

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026